Alzheimer’s disease and dementia present profound challenges in cognitive and functional decline among the elderly. While not curative, antipsychotic medications are sometimes used to manage behavioral symptoms like agitation, aggression, and hallucinations that can arise in these conditions. However, their use in dementia care is controversial due to potential side effects, including increased risk of stroke, sedation, and accelerated cognitive decline. Non-pharmacological approaches such as structured routines, cognitive stimulation, and environmental modifications are preferred whenever possible. Careful consideration by healthcare providers is essential, weighing the risks and benefits to ensure the highest quality of life for patients while minimizing adverse effects. Ongoing research aims to refine treatment strategies, emphasizing personalized care approaches tailored to the unique needs and responses of individuals with Alzheimer’s disease and other forms of dementia.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States